IndraLab

Statements


EGF inhibits COPS6. 2 / 2
| 2

reach
"Congruently, PD98059 increased the turnover rate of CSN6 in the presence of the de novo protein synthesis inhibitor cycloheximide (XREF_FIG), whereas EGF, which induced ERK activation, reduced CSN6 turnover (XREF_FIG)."

reach
"Congruently, PD98059 increased the turnover rate of CSN6 in the presence of the de novo protein synthesis inhibitor cycloheximide, whereas EGF, which induced ERK activation, reduced CSN6 turnover."